-
2
-
-
1942436088
-
The clinically inapparent adrenal mass: update in diagnosis and management
-
Mansmann G., Lau J., Balk E., et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews 25 (2004) 309-340
-
(2004)
Endocrine Reviews
, vol.25
, pp. 309-340
-
-
Mansmann, G.1
Lau, J.2
Balk, E.3
-
3
-
-
33745223866
-
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
-
Bovio S., Cataldi A., Reimondo G., et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. Journal of Endocrinological Investigation 29 (2006) 298-302
-
(2006)
Journal of Endocrinological Investigation
, vol.29
, pp. 298-302
-
-
Bovio, S.1
Cataldi, A.2
Reimondo, G.3
-
4
-
-
43649087703
-
The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy
-
Song J.H., Chaudhry F.S., and Mayo-Smith W.W. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR American Journal of Roentgenology 190 (2008) 1163-1168
-
(2008)
AJR American Journal of Roentgenology
, vol.190
, pp. 1163-1168
-
-
Song, J.H.1
Chaudhry, F.S.2
Mayo-Smith, W.W.3
-
6
-
-
0034651712
-
Adrenocortical carcinoma: clinical and laboratory observations
-
Wajchenberg B., Albergaria P.M., Medonca B., et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88 (2000) 711-736
-
(2000)
Cancer
, vol.88
, pp. 711-736
-
-
Wajchenberg, B.1
Albergaria, P.M.2
Medonca, B.3
-
9
-
-
33646593777
-
Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
-
Kebebew E., Reiff E., Duh Q.Y., et al. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?. World Journal of Surgery 30 (2006) 872-878
-
(2006)
World Journal of Surgery
, vol.30
, pp. 872-878
-
-
Kebebew, E.1
Reiff, E.2
Duh, Q.Y.3
-
10
-
-
0025248241
-
Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy
-
Luton J.P., Cerdas S., Billaud L., et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. The New England Journal of Medicine 322 (1990) 1195-1201
-
(1990)
The New England Journal of Medicine
, vol.322
, pp. 1195-1201
-
-
Luton, J.P.1
Cerdas, S.2
Billaud, L.3
-
11
-
-
0027497040
-
Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature
-
Wooten M.D., and King D.K. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72 (1993) 3145-3155
-
(1993)
Cancer
, vol.72
, pp. 3145-3155
-
-
Wooten, M.D.1
King, D.K.2
-
12
-
-
0034917097
-
Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group
-
Icard P., Goudet P., Charpenay C., et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World Journal of Surgery 25 (2001) 891-897
-
(2001)
World Journal of Surgery
, vol.25
, pp. 891-897
-
-
Icard, P.1
Goudet, P.2
Charpenay, C.3
-
14
-
-
33745777816
-
Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients
-
Abiven G., Coste J., Groussin L., et al. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 2650-2655
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 2650-2655
-
-
Abiven, G.1
Coste, J.2
Groussin, L.3
-
15
-
-
34249810952
-
Adrenocortical cancer: pathophysiology and clinical management
-
Libe R., Fratticci A., and Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 14 (2007) 13-28
-
(2007)
Endocr Relat Cancer
, vol.14
, pp. 13-28
-
-
Libe, R.1
Fratticci, A.2
Bertherat, J.3
-
16
-
-
16444385246
-
Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course
-
Seccia T.M., Fassina A., Nussdorfer G.G., et al. Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer 12 (2005) 149-159
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 149-159
-
-
Seccia, T.M.1
Fassina, A.2
Nussdorfer, G.G.3
-
17
-
-
66149166527
-
-
Arlt W, Hahner S, Libe R, et al. Steroid profiling in the diagnosis and monitoring of adrenocortical cancer - results of the EURINE ACC Study of the European Network For The Study Of Adrenal Tumors (ENS@T). Abstracts of the 90th annual meeting of the Endocrine Society, San Francisco; 2008. p. OR40-2.
-
Arlt W, Hahner S, Libe R, et al. Steroid profiling in the diagnosis and monitoring of adrenocortical cancer - results of the EURINE ACC Study of the European Network For The Study Of Adrenal Tumors (ENS@T). Abstracts of the 90th annual meeting of the Endocrine Society, San Francisco; 2008. p. OR40-2.
-
-
-
-
18
-
-
0033971893
-
Diagnosis and management of adrenal incidentalomas
-
Barzon L., and Boscaro M. Diagnosis and management of adrenal incidentalomas. The Journal of Urology 163 (2000) 398-407
-
(2000)
The Journal of Urology
, vol.163
, pp. 398-407
-
-
Barzon, L.1
Boscaro, M.2
-
19
-
-
0034454579
-
A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology
-
Mantero F., Terzolo M., Arnaldi G., et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 637-644
-
(2000)
The Journal of Clinical Endocrinology and Metabolism
, vol.85
, pp. 637-644
-
-
Mantero, F.1
Terzolo, M.2
Arnaldi, G.3
-
21
-
-
35948992319
-
The optimal imaging of adrenal tumours: a comparison of different methods
-
Ilias I., Sahdev A., Reznek R.H., et al. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14 (2007) 587-599
-
(2007)
Endocr Relat Cancer
, vol.14
, pp. 587-599
-
-
Ilias, I.1
Sahdev, A.2
Reznek, R.H.3
-
23
-
-
0031832517
-
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature
-
Boland G.W., Lee M.J., Gazelle G.S., et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR American Journal of Roentgenology 171 (1998) 201-204
-
(1998)
AJR American Journal of Roentgenology
, vol.171
, pp. 201-204
-
-
Boland, G.W.1
Lee, M.J.2
Gazelle, G.S.3
-
24
-
-
20044384532
-
Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience
-
Hamrahian A.H., Ioachimescu A.G., Remer E.M., et al. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 871-877
-
(2005)
The Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 871-877
-
-
Hamrahian, A.H.1
Ioachimescu, A.G.2
Remer, E.M.3
-
25
-
-
0033709244
-
Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT
-
Pena C.S., Boland G.W., Hahn P.F., et al. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217 (2000) 798-802
-
(2000)
Radiology
, vol.217
, pp. 798-802
-
-
Pena, C.S.1
Boland, G.W.2
Hahn, P.F.3
-
26
-
-
0036186857
-
Adrenal masses: characterization with combined unenhanced and delayed enhanced CT
-
Caoili E.M., Korobkin M., Francis I.R., et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222 (2002) 629-633
-
(2002)
Radiology
, vol.222
, pp. 629-633
-
-
Caoili, E.M.1
Korobkin, M.2
Francis, I.R.3
-
27
-
-
12344268844
-
Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT
-
Szolar D.H., Korobkin M., Reittner P., et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234 (2005) 479-485
-
(2005)
Radiology
, vol.234
, pp. 479-485
-
-
Szolar, D.H.1
Korobkin, M.2
Reittner, P.3
-
28
-
-
34249073502
-
Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses
-
Park B.K., Kim C.K., Kim B., et al. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243 (2007) 760-765
-
(2007)
Radiology
, vol.243
, pp. 760-765
-
-
Park, B.K.1
Kim, C.K.2
Kim, B.3
-
29
-
-
0029787115
-
Adrenal adenomas: relationship between histologic lipid and CT and MR findings
-
Korobkin M., Giordano T.J., Brodeur F.J., et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200 (1996) 743-747
-
(1996)
Radiology
, vol.200
, pp. 743-747
-
-
Korobkin, M.1
Giordano, T.J.2
Brodeur, F.J.3
-
30
-
-
0036171623
-
How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study
-
Honigschnabl S., Gallo S., Niederle B., et al. How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. European Journal of Radiology 41 (2002) 113-122
-
(2002)
European Journal of Radiology
, vol.41
, pp. 113-122
-
-
Honigschnabl, S.1
Gallo, S.2
Niederle, B.3
-
32
-
-
36248929486
-
Adrenal masses: characterization with in vivo proton MR spectroscopy-initial experience
-
Faria J.F., Goldman S.M., Szejnfeld J., et al. Adrenal masses: characterization with in vivo proton MR spectroscopy-initial experience. Radiology 245 (2007) 788-797
-
(2007)
Radiology
, vol.245
, pp. 788-797
-
-
Faria, J.F.1
Goldman, S.M.2
Szejnfeld, J.3
-
34
-
-
34247177446
-
Analysis of adrenal masses by 18F-FDG positron emission tomography scanning
-
Han S.J., Kim T.S., Jeon S.W., et al. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. International Journal of Clinical Practice 61 (2007) 802-809
-
(2007)
International Journal of Clinical Practice
, vol.61
, pp. 802-809
-
-
Han, S.J.1
Kim, T.S.2
Jeon, S.W.3
-
35
-
-
33947269897
-
Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation
-
Caoili E.M., Korobkin M., Brown R.K., et al. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation. Academic Radiology 14 (2007) 468-475
-
(2007)
Academic Radiology
, vol.14
, pp. 468-475
-
-
Caoili, E.M.1
Korobkin, M.2
Brown, R.K.3
-
38
-
-
33646027924
-
[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings
-
Hennings J., Lindhe O., Bergstrom M., et al. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 1410-1414
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 1410-1414
-
-
Hennings, J.1
Lindhe, O.2
Bergstrom, M.3
-
39
-
-
45149086838
-
[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes
-
Hahner S., Stuermer A., Kreissl M., et al. [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. The Journal of Clinical Endocrinology and Metabolism 93 (2008) 2358-2365
-
(2008)
The Journal of Clinical Endocrinology and Metabolism
, vol.93
, pp. 2358-2365
-
-
Hahner, S.1
Stuermer, A.2
Kreissl, M.3
-
40
-
-
33745781498
-
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma
-
Mackie G.C., Shulkin B.L., Ribeiro R.C., et al. Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 2665-2671
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 2665-2671
-
-
Mackie, G.C.1
Shulkin, B.L.2
Ribeiro, R.C.3
-
41
-
-
33644828239
-
Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography
-
Leboulleux S., Dromain C., Bonniaud G., et al. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 920-925
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 920-925
-
-
Leboulleux, S.1
Dromain, C.2
Bonniaud, G.3
-
42
-
-
17644399691
-
Management of patients with adrenal cancer: recommendations of an international consensus conference
-
Schteingart D.E., Doherty G.M., Gauger P.G., et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12 (2005) 667-680
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 667-680
-
-
Schteingart, D.E.1
Doherty, G.M.2
Gauger, P.G.3
-
43
-
-
47049116905
-
Pathological and molecular features of adrenocortical carcinoma: an update
-
Volante M., Buttigliero C., Greco E., et al. Pathological and molecular features of adrenocortical carcinoma: an update. Journal of Clinical Pathology 61 (2008) 787-793
-
(2008)
Journal of Clinical Pathology
, vol.61
, pp. 787-793
-
-
Volante, M.1
Buttigliero, C.2
Greco, E.3
-
45
-
-
0018719716
-
Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data
-
Hough A.J., Hollifield J.W., Page D.L., et al. Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. American Journal of Clinical Pathology 72 (1979) 390-399
-
(1979)
American Journal of Clinical Pathology
, vol.72
, pp. 390-399
-
-
Hough, A.J.1
Hollifield, J.W.2
Page, D.L.3
-
46
-
-
0021966841
-
Morphologic characteristics of benign and malignant adrenocortical tumors
-
van Slooten H., Schaberg A., Smeenk D., et al. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55 (1985) 766-773
-
(1985)
Cancer
, vol.55
, pp. 766-773
-
-
van Slooten, H.1
Schaberg, A.2
Smeenk, D.3
-
47
-
-
0027688666
-
Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms
-
Goldblum J.R., Shannon R., Kaldjian E.P., et al. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Modern Pathology 6 (1993) 663-668
-
(1993)
Modern Pathology
, vol.6
, pp. 663-668
-
-
Goldblum, J.R.1
Shannon, R.2
Kaldjian, E.P.3
-
48
-
-
0030920857
-
Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB
-
Vargas M.P., Vargas H.I., Kleiner D.E., et al. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB. American Journal of Surgical Pathology 21 (1997) 556-562
-
(1997)
American Journal of Surgical Pathology
, vol.21
, pp. 556-562
-
-
Vargas, M.P.1
Vargas, H.I.2
Kleiner, D.E.3
-
49
-
-
0035151360
-
Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors
-
Terzolo M., Boccuzzi A., Bovio S., et al. Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology 57 (2001) 176-182
-
(2001)
Urology
, vol.57
, pp. 176-182
-
-
Terzolo, M.1
Boccuzzi, A.2
Bovio, S.3
-
50
-
-
0034839753
-
Discerning malignancy in adrenocortical tumors: are molecular markers useful?
-
Wachenfeld C., Beuschlein F., Zwermann O., et al. Discerning malignancy in adrenocortical tumors: are molecular markers useful?. European Journal of Endocrinology 145 (2001) 335-341
-
(2001)
European Journal of Endocrinology
, vol.145
, pp. 335-341
-
-
Wachenfeld, C.1
Beuschlein, F.2
Zwermann, O.3
-
51
-
-
42049089568
-
Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas
-
Morimoto R., Satoh F., Murakami O., et al. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocrine Journal 55 (2008) 49-55
-
(2008)
Endocrine Journal
, vol.55
, pp. 49-55
-
-
Morimoto, R.1
Satoh, F.2
Murakami, O.3
-
52
-
-
0034477224
-
Histopathological classification of adrenal tumours
-
Saeger W. Histopathological classification of adrenal tumours. European Journal of Clinical Investigation 30 (2000) 58-62
-
(2000)
European Journal of Clinical Investigation
, vol.30
, pp. 58-62
-
-
Saeger, W.1
-
53
-
-
0037330409
-
High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients
-
Saeger W., Fassnacht M., Chita R., et al. High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Human Pathology 34 (2003) 180-186
-
(2003)
Human Pathology
, vol.34
, pp. 180-186
-
-
Saeger, W.1
Fassnacht, M.2
Chita, R.3
-
54
-
-
34347354300
-
Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma
-
Sasano H., Suzuki T., and Moriya T. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocrine Pathology 17 (2006) 345-354
-
(2006)
Endocrine Pathology
, vol.17
, pp. 345-354
-
-
Sasano, H.1
Suzuki, T.2
Moriya, T.3
-
55
-
-
3242661766
-
Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors
-
Tissier F., Louvel A., Grabar S., et al. Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors. European Journal of Endocrinology 150 (2004) 809-817
-
(2004)
European Journal of Endocrinology
, vol.150
, pp. 809-817
-
-
Tissier, F.1
Louvel, A.2
Grabar, S.3
-
56
-
-
27644431904
-
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
-
Libe R., and Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. European Journal of Endocrinology 153 (2005) 477-487
-
(2005)
European Journal of Endocrinology
, vol.153
, pp. 477-487
-
-
Libe, R.1
Bertherat, J.2
-
58
-
-
0001612824
-
Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases
-
Macfarlane D.A. Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Annals of the Royal College of Surgeons of England 23 (1958) 155-186
-
(1958)
Annals of the Royal College of Surgeons of England
, vol.23
, pp. 155-186
-
-
Macfarlane, D.A.1
-
60
-
-
59449084843
-
Limited prognostic value of the 2004 UICC staging classification for adrenocortical carcinoma - proposal for a revised TNM classification
-
Jan 15;
-
Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 UICC staging classification for adrenocortical carcinoma - proposal for a revised TNM classification. Cancer 2009 Jan 15;115(2): 243-250.
-
(2009)
Cancer
, vol.115
, Issue.2
, pp. 243-250
-
-
Fassnacht, M.1
Johanssen, S.2
Quinkler, M.3
et al4
-
61
-
-
0030779752
-
Adrenocortical carcinoma with intracaval extension
-
Hedican S.P., and Marshall F.F. Adrenocortical carcinoma with intracaval extension. The Journal of Urology 158 (1997) 2056-2061
-
(1997)
The Journal of Urology
, vol.158
, pp. 2056-2061
-
-
Hedican, S.P.1
Marshall, F.F.2
-
62
-
-
29144439154
-
Laparoscopic resection of adrenal cortical carcinoma: a cautionary note
-
[discussion: 1085-6]
-
Gonzalez R.J., Shapiro S., Sarlis N., et al. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery 138 (2005) 1078-1085 [discussion: 1085-6]
-
(2005)
Surgery
, vol.138
, pp. 1078-1085
-
-
Gonzalez, R.J.1
Shapiro, S.2
Sarlis, N.3
-
63
-
-
0036324168
-
Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms
-
[discussion: 952-3]
-
Kebebew E., Siperstein A.E., Clark O.H., et al. Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Archives of Surgery 137 (2002) 948-951 [discussion: 952-3]
-
(2002)
Archives of Surgery
, vol.137
, pp. 948-951
-
-
Kebebew, E.1
Siperstein, A.E.2
Clark, O.H.3
-
64
-
-
33846409034
-
Recurrent adrenocortical carcinoma after laparoscopic resection
-
quiz 1 p following 195
-
Schlamp A., Hallfeldt K., Mueller-Lisse U., et al. Recurrent adrenocortical carcinoma after laparoscopic resection. Nature Clinical Practice, Endocrinology & Metabolism 3 (2007) 191-195 quiz 1 p following 195
-
(2007)
Nature Clinical Practice, Endocrinology & Metabolism
, vol.3
, pp. 191-195
-
-
Schlamp, A.1
Hallfeldt, K.2
Mueller-Lisse, U.3
-
65
-
-
0027051533
-
An eleven-year experience with adrenocortical carcinoma
-
[discussion: 970-1]
-
Pommier R.F., and Brennan M.F. An eleven-year experience with adrenocortical carcinoma. Surgery 112 (1992) 963-970 [discussion: 970-1]
-
(1992)
Surgery
, vol.112
, pp. 963-970
-
-
Pommier, R.F.1
Brennan, M.F.2
-
66
-
-
0037083656
-
Adrenocortical carcinoma: clinical, morphologic, and molecular characterization
-
Stojadinovic A., Ghossein R.A., Hoos A., et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. Journal of Clinical Oncology 20 (2002) 941-950
-
(2002)
Journal of Clinical Oncology
, vol.20
, pp. 941-950
-
-
Stojadinovic, A.1
Ghossein, R.A.2
Hoos, A.3
-
68
-
-
33751529232
-
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma
-
Fassnacht M., Hahner S., Polat B., et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 4501-4504
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 4501-4504
-
-
Fassnacht, M.1
Hahner, S.2
Polat, B.3
-
69
-
-
0033767891
-
Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use
-
Khan T.S., Imam H., Juhlin C., et al. Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use. Annals of Oncology 11 (2000) 1281-1287
-
(2000)
Annals of Oncology
, vol.11
, pp. 1281-1287
-
-
Khan, T.S.1
Imam, H.2
Juhlin, C.3
-
70
-
-
0037302792
-
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases
-
Wood B.J., Abraham J., Hvizda J.L., et al. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97 (2003) 554-560
-
(2003)
Cancer
, vol.97
, pp. 554-560
-
-
Wood, B.J.1
Abraham, J.2
Hvizda, J.L.3
-
71
-
-
1642578807
-
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications
-
Rhim H., Dodd III G.D., Chintapalli K.N., et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24 (2004) 41-52
-
(2004)
Radiographics
, vol.24
, pp. 41-52
-
-
Rhim, H.1
Dodd III, G.D.2
Chintapalli, K.N.3
-
72
-
-
18444393449
-
Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation
-
Brown D.B. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation. Journal of Vascular and Interventional Radiology 16 (2005) 597-613
-
(2005)
Journal of Vascular and Interventional Radiology
, vol.16
, pp. 597-613
-
-
Brown, D.B.1
-
73
-
-
26944468635
-
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
-
Berruti A., Terzolo M., Sperone P., et al. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer 12 (2005) 657-666
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 657-666
-
-
Berruti, A.1
Terzolo, M.2
Sperone, P.3
-
77
-
-
14944378110
-
CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide
-
Chacon R., Tossen G., Loria F.S., et al. CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide. Journal of Clinical Oncology 23 (2005) 1579-1580
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 1579-1580
-
-
Chacon, R.1
Tossen, G.2
Loria, F.S.3
-
78
-
-
0037331277
-
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
-
Giordano T.J., Thomas D.G., Kuick R., et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. American Journal of Pathology 162 (2003) 521-531
-
(2003)
American Journal of Pathology
, vol.162
, pp. 521-531
-
-
Giordano, T.J.1
Thomas, D.G.2
Kuick, R.3
-
79
-
-
20144386848
-
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy
-
de Fraipont F., El Atifi M., Cherradi N., et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 1819-1829
-
(2005)
The Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 1819-1829
-
-
de Fraipont, F.1
El Atifi, M.2
Cherradi, N.3
-
81
-
-
0027250109
-
The medical treatment of Cushing's syndrome
-
Miller J.W., and Crapo L. The medical treatment of Cushing's syndrome. Endocrine Reviews 14 (1993) 443-458
-
(1993)
Endocrine Reviews
, vol.14
, pp. 443-458
-
-
Miller, J.W.1
Crapo, L.2
-
82
-
-
0034484013
-
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line
-
Fassnacht M., Hahner S., Beuschlein F., et al. New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line. European Journal of Clinical Investigation 30 Suppl. 3 (2000) 76-82
-
(2000)
European Journal of Clinical Investigation
, vol.30
, Issue.SUPPL. 3
, pp. 76-82
-
-
Fassnacht, M.1
Hahner, S.2
Beuschlein, F.3
-
83
-
-
0021849079
-
Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment
-
Contreras P., Rojas A., Biagini L., et al. Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment. Lancet 2 (1985) 151-152
-
(1985)
Lancet
, vol.2
, pp. 151-152
-
-
Contreras, P.1
Rojas, A.2
Biagini, L.3
-
84
-
-
36549032804
-
-
Johanssen S & Allolio B. Mifepristone (RU 486) in Cushing's syndrome. European Journal of Endocrinology 2007; 157: 561-569; Castinetti F, Fassnacht M, Johanssen S, et al. Merits and pitfalls of mifepristone in Cushing's syndrome. 2009 Mar 16. [Epub ahead of print].
-
Johanssen S & Allolio B. Mifepristone (RU 486) in Cushing's syndrome. European Journal of Endocrinology 2007; 157: 561-569; Castinetti F, Fassnacht M, Johanssen S, et al. Merits and pitfalls of mifepristone in Cushing's syndrome. 2009 Mar 16. [Epub ahead of print].
-
-
-
-
85
-
-
0025267796
-
Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects
-
Schulte H.M., Benker G., Reinwein D., et al. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. The Journal of Clinical Endocrinology and Metabolism 70 (1990) 1426-1430
-
(1990)
The Journal of Clinical Endocrinology and Metabolism
, vol.70
, pp. 1426-1430
-
-
Schulte, H.M.1
Benker, G.2
Reinwein, D.3
-
86
-
-
0000500594
-
Regression of adrenal cancer and suppression of adrenal function in men by o,p-DDD
-
Bergenstal D., Lipsett M., Moy R., et al. Regression of adrenal cancer and suppression of adrenal function in men by o,p-DDD. Transactions of American Physicians 72 (1959) 341
-
(1959)
Transactions of American Physicians
, vol.72
, pp. 341
-
-
Bergenstal, D.1
Lipsett, M.2
Moy, R.3
-
88
-
-
0021289017
-
The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring
-
van Slooten H., Moolenaar A.J., van Seters A.P., et al. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring. European Journal of Cancer & Clinical Oncology 20 (1984) 47-53
-
(1984)
European Journal of Cancer & Clinical Oncology
, vol.20
, pp. 47-53
-
-
van Slooten, H.1
Moolenaar, A.J.2
van Seters, A.P.3
-
89
-
-
0028208020
-
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients
-
Haak H.R., Hermans J., van de Velde C.J., et al. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. British Journal of Cancer 69 (1994) 947-951
-
(1994)
British Journal of Cancer
, vol.69
, pp. 947-951
-
-
Haak, H.R.1
Hermans, J.2
van de Velde, C.J.3
-
90
-
-
0035883416
-
Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma
-
Baudin E., Pellegriti G., Bonnay M., et al. Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer 92 (2001) 1385-1392
-
(2001)
Cancer
, vol.92
, pp. 1385-1392
-
-
Baudin, E.1
Pellegriti, G.2
Bonnay, M.3
-
91
-
-
0034457107
-
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer
-
Terzolo M., Pia A., Berruti A., et al. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 2234-2238
-
(2000)
The Journal of Clinical Endocrinology and Metabolism
, vol.85
, pp. 2234-2238
-
-
Terzolo, M.1
Pia, A.2
Berruti, A.3
-
92
-
-
33644934697
-
Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results
-
Faggiano A., Leboulleux S., Young J., et al. Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results. Clinical Endocrinology 64 (2006) 110-113
-
(2006)
Clinical Endocrinology
, vol.64
, pp. 110-113
-
-
Faggiano, A.1
Leboulleux, S.2
Young, J.3
-
93
-
-
33744959636
-
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans
-
Nader N., Raverot G., Emptoz-Bonneton A., et al. Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 2165-2170
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 2165-2170
-
-
Nader, N.1
Raverot, G.2
Emptoz-Bonneton, A.3
-
94
-
-
0031741686
-
Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
-
Dickstein G., Shechner C., Arad E., et al. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 3100-3103
-
(1998)
The Journal of Clinical Endocrinology and Metabolism
, vol.83
, pp. 3100-3103
-
-
Dickstein, G.1
Shechner, C.2
Arad, E.3
-
97
-
-
13144260715
-
Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma
-
Bellantone R., Ferrante A., Boscherini M., et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 122 (1997) 1212-1218
-
(1997)
Surgery
, vol.122
, pp. 1212-1218
-
-
Bellantone, R.1
Ferrante, A.2
Boscherini, M.3
-
99
-
-
0035447741
-
Adrenocortical carcinoma. Clinical outcome at the end of the 20th century
-
Vassilopoulou-Sellin R., and Schultz P.N. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92 (2001) 1113-1121
-
(2001)
Cancer
, vol.92
, pp. 1113-1121
-
-
Vassilopoulou-Sellin, R.1
Schultz, P.N.2
|